mycophenolic acid/betamethasone sodium phosphate (SURF-100) / Harrow Health - LARVOL DELTA

A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease (clinicaltrials.gov) - P2 | N=351 | Completed | Sponsor: Surface Pharmaceuticals, Inc. | Active, not recruiting ➔ Completed

Adverse events • Trial completion • Dry Eye Disease • Ophthalmology

A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease (clinicaltrials.gov) - P2; N=351; Active, not recruiting; Sponsor: Surface Pharmaceuticals, Inc.; Recruiting ➔ Active, not recruiting; Trial completion date: Jan 2022 ➔ Apr 2022; Trial primary completion date: Dec 2021 ➔ Mar 2022

Adverse events • Clinical • Enrollment closed • Trial completion date • Trial primary completion date • Dry Eye Disease • Ophthalmology

A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease (clinicaltrials.gov) - P2; N=280; Recruiting; Sponsor: Surface Pharmaceuticals, Inc.

Adverse events • Clinical • New P2 trial • Dry Eye Disease • Ocular Infections • Ophthalmology • Rheumatoid Arthritis